Author: Amit Bhardwaj
Abstract: The advancement of nanotechnology has revolutionized multiple fields of science, including medicine, with significant implications for vaccine development. Nanotechnology offers new ways to improve vaccine immunogenicity and stability, addressing challenges such as limited efficacy, short shelf-life, and complex production processes. This paper explores the integration of nanotechnology in vaccine design, focusing on its role in enhancing immune responses, improving stability under various environmental conditions, and facilitating the development of novel vaccine platforms, including mRNA vaccines. The paper also discusses key nanomaterial types, such as nanoparticles, liposomes, and nanocarriers, highlighting their potential in vaccine formulations. With increasing global demand for effective vaccines, especially in the context of emerging infectious diseases, nanotechnology holds promise in shaping the future of immunization.
Keywords: Nanotechnology, Vaccine Development, Immunogenicity, Stability, Nanoparticles, Liposomes, Vaccine Platforms
Full Issue
| View or download the full issue | PDF 68-74 |